328 related articles for article (PubMed ID: 3617601)
1. [Clinical importance of determining steroid hormone receptors in endometrial adenocarcinomas].
Avdeev VI; Kuz'mina ZV; Murav'eva NI; Bassalyk LS; Kozachenko VP
Vopr Onkol; 1987; 33(6):53-7. PubMed ID: 3617601
[TBL] [Abstract][Full Text] [Related]
2. [Expression of estrogen and progesterone receptors and oncoprotein HER-2 as a marker for clinical course and outcome in endometrioid adenocarcinoma of the uterine body (immunohistologic study)].
Samsonova EA; Maksimova NA; Urmancheeva AF; Pozharisskiĭ KM
Vopr Onkol; 2004; 50(2):196-201. PubMed ID: 15176223
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone receptors in uterine sarcomas.
Sutton GP; Stehman FB; Michael H; Young PC; Ehrlich CE
Obstet Gynecol; 1986 Nov; 68(5):709-14. PubMed ID: 3763088
[TBL] [Abstract][Full Text] [Related]
4. Enhanced growth of an estrogen receptor-negative endometrial adenocarcinoma by estradiol in athymic mice.
Friedl A; Gottardis MM; Pink J; Buchler DA; Jordan VC
Cancer Res; 1989 Sep; 49(17):4758-64. PubMed ID: 2758409
[TBL] [Abstract][Full Text] [Related]
5. The prognostic importance of steroid receptors in endometrial carcinoma.
Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
[TBL] [Abstract][Full Text] [Related]
6. [Steroid hormone receptors and survival in breast cancer patients].
Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
[TBL] [Abstract][Full Text] [Related]
7. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between estrogen receptor(ER), progesterone receptor(PR) and human keratin protein (hKP) in endometrial carcinoma].
Hatae M; Yagi Y
Gan No Rinsho; 1983 Dec; 29(15):1740-9. PubMed ID: 6199529
[TBL] [Abstract][Full Text] [Related]
9. [Measurement of estrogen receptor and progesterone receptor in human endometrium and endometrial carcinoma].
Itoh E
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):812-20. PubMed ID: 2196312
[TBL] [Abstract][Full Text] [Related]
10. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
[TBL] [Abstract][Full Text] [Related]
11. [Estrogen and progesterone receptors in endometrial carcinoma].
Guo Y; Dang Q
Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
[TBL] [Abstract][Full Text] [Related]
12. Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix.
Ciocca DR; Puy LA; Fasoli LC
Cancer Res; 1989 Aug; 49(15):4298-304. PubMed ID: 2743317
[TBL] [Abstract][Full Text] [Related]
13. Quality control study of estradiol and progesterone receptor determination.
Vermousek I; Számel I
Neoplasma; 1988; 35(3):307-14. PubMed ID: 3405339
[TBL] [Abstract][Full Text] [Related]
14. The distribution and prognostic implications of steroid receptors in endometrial carcinomas.
Utaaker E; Iversen OE; Skaarland E
Gynecol Oncol; 1987 Sep; 28(1):89-100. PubMed ID: 3653774
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical profile of endometrial adenocarcinoma: a study of 61 cases and review of the literature.
Kounelis S; Kapranos N; Kouri E; Coppola D; Papadaki H; Jones MW
Mod Pathol; 2000 Apr; 13(4):379-88. PubMed ID: 10786803
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic progesterone and estradiol receptors in normal, hyperplastic, and carcinomatous endometria: therapeutic implications.
Ehrlich CE; Young PC; Cleary RE
Am J Obstet Gynecol; 1981 Nov; 141(5):539-46. PubMed ID: 6457531
[TBL] [Abstract][Full Text] [Related]
17. [Histopathological changes in endometrial cancer treated with tamoxifen].
Lin HH; Ueda K; Kato J
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1038-43. PubMed ID: 3963849
[TBL] [Abstract][Full Text] [Related]
18. Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs.
van de Ven J; Sprong M; Donker GH; Thijssen JH; Mak-Kregar S; Blankenstein MA
Gynecol Endocrinol; 2001 Dec; 15 Suppl 6():61-8. PubMed ID: 12227888
[TBL] [Abstract][Full Text] [Related]
19. Relapse of endometrial carcinoma related to steroid receptor concentration, staging, histologic grading and myometrial invasion.
Lindahl B; Alm P; Fernö M; Grundsell H; Norgren A; Tropé C
Anticancer Res; 1986; 6(6):1317-20. PubMed ID: 3813487
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with prognosis in human breast cancer. IV. Progesterone receptors and clinical factors.
Macías A; Pascual MR; Pérez R; Lage A
Neoplasma; 1983; 30(5):593-601. PubMed ID: 6656963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
